Skip to main
LDOS

Leidos Hld (LDOS) Stock Forecast & Price Target

Leidos Hld (LDOS) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 45%
Buy 27%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

Leidos Holdings Inc. has demonstrated strong financial performance, particularly in its Health & Civil segment, where increased exam volumes have positively impacted margins due to economies of scale. The company's national security revenues saw a substantial 8% year-over-year growth, reaching $2.02 billion, driven by new contract awards and mission support growth, while defense systems revenues increased by 11% year-over-year to $582 million. Furthermore, the notable improvement in EBIT margins from 14.5% in 2023 to 22.5% in 2024, with a projected 24.3% margin in the first half of 2025, highlights Leidos's operational efficiency and financial health, supporting a favorable outlook for the company's stock.

Bears say

The financial outlook for Leidos Holdings Inc. appears negative primarily due to anticipated margin declines in the latter half of 2025 relative to the first half, raising concerns about overall profitability. There are additional risks associated with potential decreases in medical exam volumes, which could further pressure margins in their health services sector, compounded by governmental budget uncertainties. Moreover, factors such as legal challenges to contracts, potential government shutdowns, and international regulatory risks could adversely affect the company's operating results and overall market sentiment.

Leidos Hld (LDOS) has been analyzed by 11 analysts, with a consensus rating of Buy. 45% of analysts recommend a Strong Buy, 27% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Leidos Hld and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Leidos Hld (LDOS) Forecast

Analysts have given Leidos Hld (LDOS) a Buy based on their latest research and market trends.

According to 11 analysts, Leidos Hld (LDOS) has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $213.27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $213.27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Leidos Hld (LDOS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.